Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert W Carling

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 23, 2016
In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti-inflammatory effectsDavid F Woodward, Jenny W Wang, Ming Ni, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 1, 2015
Multitargeting of selected prostanoid receptors provides agents with enhanced anti-inflammatory activity in macrophagesJenny W Wang, David F Woodward, Jose L Martos, et al.
Investigative Ophthalmology & Visual Science|May 4, 2010
Cellular basis for bimatoprost effects on human conventional outflowW Daniel Stamer, David Piwnica, Thierry Jolas, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonistsRobert W Carling, Michael G N Russell, Kevin W Moore, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2005
Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxietySimon C Goodacre, David J Hallett, Robert W Carling, et al.
ACS Pharmacology & Translational Science|December 21, 2020
A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor SubtypesDavid F Woodward, Jenny W Wang, Clayton S Spada, et al.
Journal of Medicinal Chemistry|November 13, 2004
An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing propertiesMark S Chambers, John R Atack, Robert W Carling, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptorAndrew Mitchinson, John R Atack, Peter Blurton, et al.
ACS Chemical Neuroscience|September 19, 2018
FAAH-Catalyzed C-C Bond Cleavage of a New Multitarget Analgesic DrugAlessia Ligresti, Cristoforo Silvestri, Rosa Maria Vitale, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonistsJason M Elliott, Robert W Carling, Mark Chambers, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 23, 2016
In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti-inflammatory effectsDavid F Woodward, Jenny W Wang, Ming Ni, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 1, 2015
Multitargeting of selected prostanoid receptors provides agents with enhanced anti-inflammatory activity in macrophagesJenny W Wang, David F Woodward, Jose L Martos, et al.
Investigative Ophthalmology & Visual Science|May 4, 2010
Cellular basis for bimatoprost effects on human conventional outflowW Daniel Stamer, David Piwnica, Thierry Jolas, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2006
2,3,7-Trisubstituted pyrazolo[1,5-d][1,2,4]triazines: functionally selective GABAA alpha3-subtype agonistsRobert W Carling, Michael G N Russell, Kevin W Moore, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2005
Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxietySimon C Goodacre, David J Hallett, Robert W Carling, et al.
ACS Pharmacology & Translational Science|December 21, 2020
A Second Generation Prostanoid Receptor Antagonist Acting at Multiple Receptor SubtypesDavid F Woodward, Jenny W Wang, Clayton S Spada, et al.
Journal of Medicinal Chemistry|November 13, 2004
An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing propertiesMark S Chambers, John R Atack, Robert W Carling, et al.
Bioorganic & Medicinal Chemistry Letters|June 5, 2004
2,5-Dihydropyrazolo[4,3-c]pyridin-3-ones: functionally selective benzodiazepine binding site ligands on the GABAA receptorAndrew Mitchinson, John R Atack, Peter Blurton, et al.
ACS Chemical Neuroscience|September 19, 2018
FAAH-Catalyzed C-C Bond Cleavage of a New Multitarget Analgesic DrugAlessia Ligresti, Cristoforo Silvestri, Rosa Maria Vitale, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
N',2-diphenylquinoline-4-carbohydrazide based NK3 receptor antagonistsJason M Elliott, Robert W Carling, Mark Chambers, et al.
Pageof 2